Astellas Pharma Inc. (ALPMF) Stock Split, History Data
Working capital analysis
In terms of working capital, Astellas Pharma Inc. maintains a healthy position.
The total current assets of the company are valued at $1194730000000.
This represents a growth rate of 13.789% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $335687000000, exhibiting a growth rate of -10.921% year-on-year.
The receivables, another significant portion of the current assets, are valued at $548036000000.
The year-on-year growth rate for receivables is 22.736%.
The inventory, which forms a critical part of the assets, is valued at $248738000000.
This represents a healthy year-on-year growth of 42.636%
On the liabilities side, the company's current liabilities total $1285725000000.
This reflects a growth rate of 77.089% over the previous year, indicating the company's financial obligations are well under control.
2024
2023
2022
2021
2020
2019
Cash and investments
335687.00
376840.00
315986.00
326128.00
318391.00
311074.00
Receavebles
548036.00
446516.00
404001.00
357162.00
370598.00
366888.00
Inventory
248738.00
174386.00
153072.00
164080.00
151017.00
151511.00
Other
62269.00
32428.00
28998.00
19658.00
18049.00
25079.00
Total Current Assets
1194730.00
1049954.00
923354.00
872588.00
867514.00
857159.00
Acc Payable
185193.00
140236.00
130739.00
124777.00
171954.00
185280.00
Short Term Debt
472278.00
88546.00
157730.00
136101.00
344105.00
430.00
Other Current Liab
589739.00
585798.00
556672.00
467595.00
270954.00
298635.00
Current Liabilities
1285725.00
726034.00
687411.00
592372.00
798708.00
497665.00
Capital Structure
When examining the capital structure of Astellas Pharma Inc., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Astellas Pharma Inc. has chosen to reinvest in the business rather than distribute as dividends.
